DDrare
Disease
Drug
Target Gene/Pathway
問合せ先
EN
Fluorescite
( DrugBank: - / KEGG DRUG: - )
1 disease
告示番号
疾患名
(ページ内リンク)
臨床試験数
215
ファロー四徴症
1
215. ファロー四徴症
臨床試験数
:
18
/
薬物数
:
26
- (
DrugBank
:
14
) /
標的遺伝子数
:
13
-
標的パスウェイ数
:
45
10
50
100
ALL
trials per page:
Showing 1 to 1 of 1 trials
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
NCT04017975
(
ClinicalTrials.gov
)
December 20, 2019
20191220
10/7/2019
20190710
Optical Tissue Identification for Myocardial Architecture
Optical Tissue Identification for Myocardial Architecture (OPTIMA Study)
Ventricular Septal Defect;Complete Atrioventricular Canal;Tetralogy of Fallot With Pulmonary Stenosis
Ventricular Septal Defect;Complete Atrioventricular Canal;Tetralogy of Fallot With Pulmonary Stenosi ...
Drug:
Fluorescite
;Device: Cellvizio 100 Series System with Confocal Miniprobes
Aditya Kaza
National Heart, Lung, and Blood Institute (NHLBI)
Active, not recruiting
30 Days
18 Years
All
70
Phase 2
United States